{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T04:06:58Z","timestamp":1727150818415},"posted":{"date-parts":[[2024,5,20]]},"group-title":"In Review","reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,5,4]]},"abstract":"<title>Abstract<\/title>\n        <p>Alpha-synuclein (\u03b1Syn) forms pathologic aggregates in Parkinson\u2019s disease (PD) and is implicated in mechanisms underlying neurodegeneration. While pathologic \u03b1Syn has been extensively studied, there is currently no method to evaluate \u03b1Syn within the brains of living patients. Patients with PD are often treated with deep brain stimulation (DBS) surgery in which surgical instruments are in direct contact with neuronal tissue; herein, we describe a method by which tissue is purified from DBS surgical instruments in PD and essential tremor (ET) patients and demonstrate that \u03b1Syn is robustly detected. 24 patients undergoing DBS surgery for PD (17 patients) or ET (7 patients) were enrolled; from patient samples, 81.2 \u00b1 44.8 \u00b5g protein (n=15) is able to be purified, with immunoblot assays specific for \u03b1Syn reactive in all tested samples. Light microscopy revealed axons and capillaries as the primary components of purified tissue (n=3). Further analysis was conducted using western blot, demonstrating that truncated \u03b1Syn (1-125 \u03b1Syn) was significantly increased in PD (n=5) compared to ET (n=3), in which \u03b1Syn misfolding is not expected (0.64 \u00b1 0.25 vs. 0.25 \u00b1 0.12, P = 0.046), thus showing that pathologic \u03b1Syn can be reliably purified from living PD patients with this method.<\/p>","DOI":"10.21203\/rs.3.rs-4369598\/v1","type":"posted-content","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T19:04:27Z","timestamp":1716231867000},"source":"Crossref","is-referenced-by-count":0,"title":["Analysis of alpha-synuclein harvested from intra-cranial instruments used in deep brain stimulation surgery for Parkinson\u2019s disease"],"prefix":"10.21203","author":[{"given":"zachary","family":"sorrentino","sequence":"first","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Riklan","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Lloyd","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Lucke-Wold","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mampre","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Quintin","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasheedat","family":"Zakare-Fagbamila","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Still","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vyshak","family":"Chandra","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Foote","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Giasson","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Hilliard","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","article-title":"The emerging role of \u03b1-synuclein truncation in aggregation and disease","volume":"295","author":"Sorrentino ZA","year":"2020","unstructured":"Sorrentino, Z. A. & Giasson, B. I. The emerging role of \u03b1-synuclein truncation in aggregation and disease. J Biol Chem 295, 10224\u201310244 (2020). https:\/\/doi.org:10.1074\/jbc.REV120.011743","journal-title":"J Biol Chem"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-019-01977-2","article-title":"\u03b1-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease","volume":"138","author":"Sorrentino ZA","year":"2019","unstructured":"Sorrentino, Z. A., Giasson, B. I. & Chakrabarty, P. \u03b1-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease. Acta neuropathologica 138, 1\u201321 (2019). https:\/\/doi.org:10.1007\/s00401-019-01977-2","journal-title":"Acta neuropathologica"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris HR","year":"2024","unstructured":"Morris, H. R., Spillantini, M. G., Sue, C. M. & Williams-Gray, C. H. The pathogenesis of Parkinson's disease. Lancet (London, England) 403, 293\u2013304 (2024). https:\/\/doi.org:10.1016\/s0140-6736(23)01478-2","journal-title":"Lancet (London, England)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/s0140-6736(21)00218-x","article-title":"Parkinson's disease","volume":"397","author":"Bloem BR","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson's disease. Lancet (London, England) 397, 2284\u20132303 (2021). https:\/\/doi.org:10.1016\/s0140-6736(21)00218-x","journal-title":"Lancet (London, England)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/neup.12691","article-title":"Where and how alpha-synuclein pathology spreads in Parkinson's disease","volume":"40","author":"Wakabayashi K","year":"2020","unstructured":"Wakabayashi, K. Where and how alpha-synuclein pathology spreads in Parkinson's disease. Neuropathology 40, 415\u2013425 (2020). https:\/\/doi.org:10.1111\/neup.12691","journal-title":"Neuropathology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia LV","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson's disease. Lancet (London, England) 386, 896\u2013912 (2015). https:\/\/doi.org:10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet (London, England)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"120190","DOI":"10.1016\/j.jns.2022.120190","article-title":"Deep brain stimulation for the treatment of tremor","volume":"435","author":"Chandra V","year":"2022","unstructured":"Chandra, V., Hilliard, J. D. & Foote, K. D. Deep brain stimulation for the treatment of tremor. J Neurol Sci 435, 120190 (2022). https:\/\/doi.org:10.1016\/j.jns.2022.120190","journal-title":"J Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/ane.13101","article-title":"Neuroimaging and neuropathological findings in essential tremor","volume":"139","author":"Mavroudis I","year":"2019","unstructured":"Mavroudis, I., Petridis, F. & Kazis, D. Neuroimaging and neuropathological findings in essential tremor. Acta Neurol Scand 139, 491\u2013496 (2019). https:\/\/doi.org:10.1111\/ane.13101","journal-title":"Acta Neurol Scand"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2018.09.005","article-title":"Motor neuron loss and neuroinflammation in a model of \u03b1-synuclein-induced neurodegeneration","volume":"120","author":"Sorrentino ZA","year":"2018","unstructured":"Sorrentino, Z. A. et al. Motor neuron loss and neuroinflammation in a model of \u03b1-synuclein-induced neurodegeneration. Neurobiol Dis 120, 98\u2013106 (2018). https:\/\/doi.org:10.1016\/j.nbd.2018.09.005","journal-title":"Neurobiol Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk KC","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. The Journal of experimental medicine 209, 975\u2013986 (2012). https:\/\/doi.org:10.1084\/jem.20112457","journal-title":"The Journal of experimental medicine"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41374-019-0195-z","article-title":"Transmission of \u03b1-synuclein seeds in neurodegenerative disease: recent developments","volume":"99","author":"Karpowicz RJ","year":"2019","unstructured":"Karpowicz, R. J., Jr., Trojanowski, J. Q. & Lee, V. M. Transmission of \u03b1-synuclein seeds in neurodegenerative disease: recent developments. Lab Invest 99, 971\u2013981 (2019). https:\/\/doi.org:10.1038\/s41374-019-0195-z","journal-title":"Lab Invest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.005603","article-title":"Physiological C-terminal truncation of \u03b1-synuclein potentiates the prion-like formation of pathological inclusions","volume":"293","author":"Sorrentino ZA","year":"2018","unstructured":"Sorrentino, Z. A. et al. Physiological C-terminal truncation of \u03b1-synuclein potentiates the prion-like formation of pathological inclusions. The Journal of biological chemistry 293 (2018). https:\/\/doi.org:10.1074\/jbc.RA118.005603","journal-title":"The Journal of biological chemistry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-017-0182-z","article-title":"Intrastriatal injection of alpha-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity","volume":"12","author":"Sorrentino ZA","year":"2017","unstructured":"Sorrentino, Z. A. et al. Intrastriatal injection of alpha-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity. Molecular neurodegeneration 12, 40 (2017). https:\/\/doi.org:10.1186\/s13024-017-0182-z","journal-title":"Molecular neurodegeneration"},{"issue":"Suppl 1","key":"ref14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s1353-8020(13)70022-1","article-title":"Modeling Lewy pathology propagation in Parkinson's disease","volume":"20","author":"Luk KC","year":"2014","unstructured":"Luk, K. C. & Lee, V. M. Modeling Lewy pathology propagation in Parkinson's disease. Parkinsonism & related disorders 20 Suppl 1, S85\u201387 (2014). https:\/\/doi.org:10.1016\/s1353-8020(13)70022-1","journal-title":"Parkinsonism & related disorders"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"135017","DOI":"10.1016\/j.neulet.2020.135017","article-title":"Carboxy-terminal truncation and phosphorylation of \u03b1-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy","volume":"732","author":"Sorrentino ZA","year":"2020","unstructured":"Sorrentino, Z. A. et al. Carboxy-terminal truncation and phosphorylation of \u03b1-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy. Neurosci Lett 732, 135017 (2020). https:\/\/doi.org:10.1016\/j.neulet.2020.135017","journal-title":"Neurosci Lett"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s40478-021-01242-2","article-title":"Disease-, region- and cell type specific diversity of \u03b1-synuclein carboxy terminal truncations in synucleinopathies","volume":"9","author":"Hass EW","year":"2021","unstructured":"Hass, E. W. et al. Disease-, region- and cell type specific diversity of \u03b1-synuclein carboxy terminal truncations in synucleinopathies. Acta neuropathologica communications 9, 146 (2021). https:\/\/doi.org:10.1186\/s40478-021-01242-2","journal-title":"Acta neuropathologica communications"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40478-023-01623-9","article-title":"Carboxyl truncation of \u03b1-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of \u03b1-synuclein pathogenesis","volume":"11","author":"Lloyd GM","year":"2023","unstructured":"Lloyd, G. M. et al. Carboxyl truncation of \u03b1-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of \u03b1-synuclein pathogenesis. Acta neuropathologica communications 11, 119 (2023). https:\/\/doi.org:10.1186\/s40478-023-01623-9","journal-title":"Acta neuropathologica communications"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"104912","DOI":"10.1016\/j.jbc.2023.104912","article-title":"Cellular processing of \u03b1-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114","volume":"299","author":"Quintin S","year":"2023","unstructured":"Quintin, S. et al. Cellular processing of \u03b1-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114. J Biol Chem 299, 104912 (2023). https:\/\/doi.org:10.1016\/j.jbc.2023.104912","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-022-01468-8","article-title":"Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders","volume":"10","author":"Altay MF","year":"2022","unstructured":"Altay, M. F., Liu, A. K. L., Holton, J. L., Parkkinen, L. & Lashuel, H. A. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders. Acta neuropathologica communications 10, 163 (2022). https:\/\/doi.org:10.1186\/s40478-022-01468-8","journal-title":"Acta neuropathologica communications"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.1074\/jbc.RA119.008930","article-title":"C-terminal \u03b1-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease","volume":"294","author":"McGlinchey RP","year":"2019","unstructured":"McGlinchey, R. P. et al. C-terminal \u03b1-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease. J Biol Chem 294, 9973\u20139984 (2019). https:\/\/doi.org:10.1074\/jbc.RA119.008930","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153785","author":"Higuchi MA","year":"2016","unstructured":"Higuchi, M. A. et al. Interdisciplinary Parkinson's Disease Deep Brain Stimulation Screening and the Relationship to Unintended Hospitalizations and Quality of Life. PloS one 11 (2016). https:\/\/doi.org:10.1371\/journal.pone.0153785"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145623","author":"Higuchi MA","year":"2015","unstructured":"Higuchi, M. A. et al. Impact of an Interdisciplinary Deep Brain Stimulation Screening Model on Post-Surgical Complications in Essential Tremor Patients. PloS one 10 (2015). https:\/\/doi.org:10.1371\/journal.pone.0145623"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-020-00220-5","article-title":"Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson's Disease: Expert Review and Commentary","volume":"10","author":"Au KLK","year":"2021","unstructured":"Au, K. L. K. et al. Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson's Disease: Expert Review and Commentary. Neurology and therapy 10 (2021). https:\/\/doi.org:10.1007\/s40120-020-00220-5","journal-title":"Neurology and therapy"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/wnl.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith IG","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017). https:\/\/doi.org:10.1212\/wnl.0000000000004058","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/(sici)1097-4547(20000215)59:4<528::Aid-jnr8>3.0.Co;2-0","article-title":"A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease","volume":"59","author":"Giasson BI","year":"2000","unstructured":"Giasson, B. I. et al. A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease. J Neurosci Res 59, 528\u2013533 (2000). https:\/\/doi.org:10.1002\/(sici)1097-4547(20000215)59:4<528::Aid-jnr8>3.0.Co;2-0","journal-title":"J Neurosci Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40478-019-0787-2","article-title":"Unique \u03b1-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression","volume":"7","author":"Sorrentino ZA","year":"2019","unstructured":"Sorrentino, Z. A. et al. Unique \u03b1-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression. Acta neuropathologica communications 7, 142 (2019). https:\/\/doi.org:10.1186\/s40478-019-0787-2","journal-title":"Acta neuropathologica communications"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson JP","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281, 29739\u201329752 (2006). https:\/\/doi.org:10.1074\/jbc.M600933200","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/jpd-160779","article-title":"Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?","volume":"6","author":"Oueslati A","year":"2016","unstructured":"Oueslati, A. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade? J Parkinsons Dis 6, 39\u201351 (2016). https:\/\/doi.org:10.3233\/jpd-160779","journal-title":"J Parkinsons Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3233\/jad-171013","article-title":"A Longitudinal Study of Total and Phosphorylated \u03b1-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment","volume":"61","author":"Wang H","year":"2018","unstructured":"Wang, H. et al. A Longitudinal Study of Total and Phosphorylated \u03b1-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. J Alzheimers Dis 61, 1541\u20131553 (2018). https:\/\/doi.org:10.3233\/jad-171013","journal-title":"J Alzheimers Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3389\/fnins.2019.00889","article-title":"Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay","volume":"13","author":"Cariulo C","year":"2019","unstructured":"Cariulo, C. et al. Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay. Front Neurosci 13, 889 (2019). https:\/\/doi.org:10.3389\/fnins.2019.00889","journal-title":"Front Neurosci"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4369598\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4369598\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T16:15:02Z","timestamp":1727108102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4369598\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":30,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4369598\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41598-024-72542-5","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,5,20]]},"subtype":"preprint"}}